Effect of pre-contraction on β-adrenoceptor-mediated relaxation of rat urinary bladder

Martin Christian Michel, Carsten Sand, Martin Christian Michel, Carsten Sand

Abstract

Purpose: The human physiological bladder contraction is largely mediated by acetylcholine acting on muscarinic receptors, but in pathophysiological settings the relative role of non-cholinergic stimuli gains importance. β-Adrenoceptor agonists are currently in clinical development as treatments for the overactive bladder syndrome. Therefore, we have explored the ability of the β-adrenoceptor agonist isoprenaline to induce rat isolated bladder strip relaxation on pre-contraction with the muscarinic agonist carbachol as compared to bladder tone induced by several non-cholinergic stimuli.

Methods: Bladder tone was induced by passive tension, receptor independently by KCl, carbachol, bradykinin or serotonin. Concentration–response curves were generated for relaxation by isoprenaline, and a single concentration of the receptor-independent relaxant forskolin was also tested.

Results: The various contractile stimuli induced different degrees of bladder tone, but the ability of isoprenaline or forskolin to relax rat bladder was not correlated with the degree of tone. Isoprenaline was significantly less potent and effective in causing relaxation against carbachol-induced tone than against any other stimulus, whereas no such relationship was observed for forskolin.

Conclusions: We conclude that β-adrenoceptor agonists can induce rat bladder relaxation against a wide range of contractile stimuli and are more potent and/or effective against non-cholinergic stimuli than against muscarinic agonism. This profile appears desirable for agents intended for the treatment of overactive bladder.

Figures

Fig. 1
Fig. 1
Relaxation of rat urinary bladder strips by isoprenaline in relationship to pre-contraction stimulus. Data are means ± SEM of 6–8 experiments. A quantitative analysis of the data is shown in Table 1
Fig. 2
Fig. 2
Relationship between strength of pre-contraction on the relaxation responses to forskolin (top panel) and isoprenaline (middle panel for maximum effect and bottom panel for potency). Data are means ± SEM of 6–8 experiments

References

    1. Hegde SS. Muscarinic receptors in the bladder: from basic research to therapeutics. Br J Pharmacol. 2006;147:S80–S87. doi: 10.1038/sj.bjp.0706560.
    1. Sibley GN. A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol. 1984;354:431–443.
    1. Fry CH, Wu C, Mundy AR. Bladder instability and detrusor smooth muscle function. Exp Physiol. 1999;84:161–169.
    1. Yoshida M, Homma Y, Inadome A, et al. Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol. 2001;36:99–109. doi: 10.1016/S0531-5565(00)00175-3.
    1. Rapp DE, Lyon MB, Bales GT, et al. A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol. 2005;48:303–308. doi: 10.1016/j.eururo.2005.04.019.
    1. Yoshida M, Masunaga K, Satoji Y, et al. Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in urothelium and its clinical significance. J Pharmacol Sci. 2008;106:193–198. doi: 10.1254/jphs.FM0070115.
    1. Chapple CR, Khullar V, Gabriel Z, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54:543–562. doi: 10.1016/j.eururo.2008.06.047.
    1. Novara G, Galfano A, Secco S, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol. 2008;54:740–764. doi: 10.1016/j.eururo.2008.06.080.
    1. Andersson K-E, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004;84:935–986. doi: 10.1152/physrev.00038.2003.
    1. Michel MC, Vrydag W. α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol. 2006;147:S88–S119. doi: 10.1038/sj.bjp.0706619.
    1. Chapple CR, Yamaguchi O, Ridder A, et al. Clinical proof of concept study (Blossom) shows novel β3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder. Eur Urol Suppl. 2008;7:239.
    1. Longhurst PA, Levendusky M. Pharmacological characterization of β-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol. 1999;127:1744–1750. doi: 10.1038/sj.bjp.0702709.
    1. Frazier EP, Schneider T, Michel MC. Effects of gender, age and hypertension on β-adrenergic receptor function in rat urinary bladder. Naunyn Schmiedebergs Arch Pharmacol. 2006;373:300–309. doi: 10.1007/s00210-006-0077-y.
    1. Frazier EP, Peters SLM, Braverman AS, et al. Signal transduction underlying control of urinary bladder smooth muscle tone by muscarinic receptors and β-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:449–462. doi: 10.1007/s00210-007-0208-0.
    1. Otsuka A, Shinbo H, Matsumoto R, et al. Expression and functional role of β-adrenoceptors in the human urinary bladder. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:473–481. doi: 10.1007/s00210-008-0274-y.
    1. Frazier EP, Mathy M-J, Peters SLM, et al. Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol? J Pharmacol Exp Ther. 2005;313:260–267. doi: 10.1124/jpet.104.077768.
    1. Michel MC, Parra S. Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:217–224. doi: 10.1007/s00210-008-0316-5.
    1. Sarria B, Naline E, Zhang Y, et al. Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus. Am J Physiol. 2002;283:L1125–L1132.
    1. Naline E, Trifilieff A, Fairhurst RA, et al. Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi. Eur Respir J. 2007;29:575–581. doi: 10.1183/09031936.00032806.
    1. Hegde SS, Choppin A, Bonhaus D, et al. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol. 1997;120:1409–1417. doi: 10.1038/sj.bjp.0701048.
    1. Ehlert FJ, Ahn S, Pak KJ, et al. Neuronally released acetylcholine acts on the M2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder. J Pharmacol Exp Ther. 2007;322:631–637. doi: 10.1124/jpet.107.121756.
    1. Braverman AS, Doumanian LR, Ruggieri MR., Sr M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. II. Denervated rat bladder. J Pharmacol Exp Ther. 2006;316:875–880. doi: 10.1124/jpet.105.094961.
    1. Uchida H, Shishido K, Nomiya M, et al. Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via β-adrenoceptors. Eur J Pharmacol. 2005;518:195–202. doi: 10.1016/j.ejphar.2005.06.029.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir